Pharma Workforce Denmark ApS: Financial statements 2026
CVR: 45480704
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
Pharma Workforce Denmark ApS (CVR 45480704) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 481,688 and a net result of DKK 373,824. Equity in the 2026 report amounted to DKK 385,987. The solvency ratio was 59.2%.
- Gross Profit
- DKK 481,688
- Profit/Loss
- DKK 373,824
- Equity
- DKK 385,987
- Total Assets
- DKK 652,380
- Employees
- 0
Official annual report
Find more companies like Pharma Workforce Denmark ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Address changed to Strøby Bygade 16, 4671 Strøby (October 2, 2026).
Contact info changed: new phone: 53555945, new email: [email protected], new website: phawo.dk (October 2, 2026).
Pharma Workforce Denmark ApS has published its interim report for the period March 14, 2025 to June 30, 2025.
Contact info changed: new phone: 53555945, new email: [email protected], new website: phawo.dk (February 19, 2026).
Contact info changed: new phone: 53555945, new email: [email protected], new website: phawo.dk (February 6, 2026).
As of February 6, 2026, Lasse Vindahl is registered as adm. dir. of Pharma Workforce Denmark ApS.
As of February 5, 2026, Steffen Stenbøg Jensen has stepped down as director of Pharma Workforce Denmark ApS.
As of February 5, 2026, Lasse Vindahl has stepped down as director of Pharma Workforce Denmark ApS.
About Pharma Workforce Denmark ApS
Pharma Workforce Denmark ApS is a Danish company of the type Anpartsselskab based in Strøby, founded in 2025. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lasse Vindahl. The company is owned by SL Holding 2017 ApS and Vindahl Holding ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 481,688 and a net result of DKK 373,824. Equity in the 2026 report amounted to DKK 385,987.